SCHEMBL19863780

SCHEMBL19863780

CCOC(OCC)c1nc2cc(Cl)ccc2n1Cc1ccc(OC)cc1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TBXA2R P21731 1/20 0.52
ALOX5AP P20292 4/20 0.48
DCTPP1 Q9H773 2/20 0.48
TP53 P04637 3/20 0.47
CCR2 P41597 1/20 0.47
ALDH1A1 P00352 2/20 0.45
HTT P42858 2/20 0.45
POLB P06746 2/20 0.45
SMN1; SMN2 Q16637 3/20 0.43
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.43
CNR2 P34972 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MAPT P10636 3/20 0.43
GAA P10253 1/20 0.43
TDP1 Q9NUW8 2/20 0.42
KMT2A Q03164 2/20 0.42
TRPC5 Q9UL62 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19863781 0.75 TBXA2R (0.57) TBXA2RDCTPP1TP53CCR2ALDH1A1
SCHEMBL15685233 0.74 BACE1 (0.44) TP53TDP1KMT2A
SCHEMBL18890528 0.72 TP53 (0.55) TBXA2RDCTPP1TP53CCR2ALDH1A1
SCHEMBL23535783 0.70 DCTPP1 (0.46) TBXA2RDCTPP1TP53CCR2ALDH1A1
SCHEMBL31019833 0.70 CCR2 (0.58) TBXA2RDCTPP1TP53CCR2ALDH1A1
SCHEMBL22955887 0.70 TP53 (0.58) TBXA2RDCTPP1TP53CCR2ALDH1A1
SCHEMBL5246941 0.70 DCTPP1 (0.66) TBXA2RALOX5APDCTPP1TP53CCR2
SCHEMBL9683103 0.70 TBXA2R (0.79) TBXA2RALOX5APCCR2
SCHEMBL6085466 0.69 CCR2 (0.67) TBXA2RDCTPP1TP53CCR2ALDH1A1
SCHEMBL9681521 0.68 TBXA2R (1.00) TBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10577349-B2 Quinolinones as inhibitors of translation initiation complex Sanford Burnham Prebys Medical Discovery Institute (US) 2020-03-03 US disclosed
US-20180044324-A1 Quinolinones as Inhibitors of Translation Initiation Complex Sanford Burnham Prebys Medical Discovery Institute 2018-02-15 US disclosed
US-20180044324-A1 Quinolinones as Inhibitors of Translation Initiation Complex Sanford Burnham Prebys Medical Discovery Institute 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180044324-A1 Quinolinones as Inhibitors of Translation Initiation Complex EIF4E, EIF4A1, EIF4A2 TBXA2R 3849/4885ALOX5AP 4363/4885DCTPP1 1636/4885
US-10577349-B2 Quinolinones as inhibitors of translation initiation complex EIF4E, EIF4A1, EIF4A2 TBXA2R 3849/4885ALOX5AP 4363/4885DCTPP1 1636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.